Skip to content

Diabetic Retinopathy Screening in General Practice

Diabetic Retinopathy Screenings in General Practice for People With Type 2 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05276778
Enrollment
300
Registered
2022-03-11
Start date
2022-02-28
Completion date
2023-11-14
Last updated
2025-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy, Type2 Diabetes

Keywords

Artificial Intelligence, Diabetic Retinopathy Screening, General practice, Primary care, Type 2 diabetes

Brief summary

Diabetic Retinopathy is a microvascular eye complication of diabetes, which can go unnoticed until permanent vision damage has occurred - in worst-case blindness. Timely retinopathy screenings reduce the risk of sight loss since the disease can be treated if detected in time. For people with type 2 diabetes, retinopathy screenings are typically performed by specialist at private ophthalmologists' practices, and individualized screening intervals based on retinopathy level and diabetes regulation are recommended. Unfortunately, 26% of people with type 2 diabetes do not follow their screening interval, and the attendance is too low compared to the national standard of minimum 90% of patients with diabetes who ought to follow the screening program. Consequently, actions must be taken to improve screening attendance in Denmark. The aim of this study is to investigate patients' acceptance of diabetic retinopathy screenings in general practice. Patients' acceptance is explored through a questionnaire developed for the study.

Interventions

Screenings are performed in the diabetes consultation in general practice

Sponsors

Aalborg University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with type 2 diabetes * Understands Danish * Age between 18-70

Exclusion criteria

* Blindness * Cannot partake in second screening

Design outcomes

Primary

MeasureTime frameDescription
Patients' acceptance of diabetic retinopathy screenings in general practice1 day (the questionnarie is fufilled one time after the retinopaty screening in general practice)Questionnaire

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026